JEB: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 44: | Line 44: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Latest revision as of 12:56, 18 March 2025
Junctional Epidermolysis Bullosa (JEB) is a rare genetic disorder that primarily affects the skin and mucous membranes. It is characterized by blister formation within the lamina lucida of the basement membrane zone.
Symptoms[edit]
The symptoms of JEB vary widely among affected individuals. They may include:
- Blister formation on the skin and mucous membranes
- Skin fragility
- Nail dystrophy
- Dental abnormalities
- Scarring
- Alopecia (hair loss)
- Anemia
- Growth retardation
- Respiratory problems
- Dysphagia (difficulty swallowing)
Causes[edit]
JEB is caused by mutations in the genes that encode for the proteins laminin-332, type XVII collagen, and integrin α6β4. These proteins are essential for the proper formation and functioning of the hemidesmosome, a structure that helps attach the epidermis (the outer layer of skin) to the underlying dermis.
Diagnosis[edit]
The diagnosis of JEB is typically made based on the presence of characteristic clinical features. This may be confirmed by skin biopsy, electron microscopy, immunofluorescence mapping, and/or genetic testing.
Treatment[edit]
There is currently no cure for JEB. Treatment is primarily supportive and may include:
- Wound care to prevent infection and promote healing
- Pain management
- Nutritional support
- Physical and occupational therapy
- Regular dental care
- Regular monitoring for complications
Prognosis[edit]
The prognosis for individuals with JEB varies widely and depends on the specific subtype of the disorder. Some individuals with milder forms of JEB may have a normal lifespan, while those with more severe forms may experience life-threatening complications in infancy or early childhood.


